Search research articles
Contact Us
Filters
Showing results (41-50 of 333) with videos related to
Page
of 34
Sort By:
Journal of Interferon Research
|
January 1, 1982
Clinical and immunological study of beta interferon by intramuscular route in patients with metastatic breast cancer
J R Quesada, J U Gutterman, E M Hersh
Annual Review of Medicine
|
January 1, 1977
BCG as adjuvant immunotherapy for neoplasia
E M Hersh, J U Gutterman, G M Mavligit
Surgical Neurology
|
September 1, 1973
Primary brain tumors: tumor immunity and immunocompetence
G M Mavligit, J U Gutterman, E M Hersh
Cancer Treatment Reviews
|
March 1, 1974
Perspectives in immunotherapy of lung cancer
E M Hersh, J U Gutterman, G M Mavligit
Pathobiology Annual
|
January 1, 1975
Cancer and host defense mechanisms
E M Hersh, J U Gutterman, G M Mavligit
Bone Marrow Transplantation
|
January 1, 1989
Clinical studies with interferons in Philadelphia positive chronic myelogenous leukemia
M Talpaz, H Kantarjian, R Kurzrock, et al.
Seminars in Oncology
|
September 1, 1974
Immunotherapy as related to lung cancer: a review
E M Hersh, G M Mavligit, J U Gutterman
Cancer
|
January 15, 1992
Bone marrow hypoplasia and aplasia complicating interferon therapy for chronic myelogenous leukemia
M Talpaz, H Kantarjian, R Kurzrock, et al.
The Medical Clinics of North America
|
May 1, 1976
Chemoimmunotherapy of human solid tumors
J U Gutterman, G M Mavligit, E M Hersh
Journal of the National Cancer Institute
|
October 1, 1976
Effect of BCG (Tice strain) on primary sensitization to 2,4-dinitrochlorobenzene and on established delayed hypersensitivity in human malignant melanoma
G M Mavligit, J U Gutterman, E M Hersh
Page
of 34
Search research articles
Search
Showing results (41-50 of 333) with videos related to
Sort By:
Page
of 34
Journal of Interferon Research
|
January 1, 1982
Clinical and immunological study of beta interferon by intramuscular route in patients with metastatic breast cancer
J R Quesada, J U Gutterman, E M Hersh
Annual Review of Medicine
|
January 1, 1977
BCG as adjuvant immunotherapy for neoplasia
E M Hersh, J U Gutterman, G M Mavligit
Surgical Neurology
|
September 1, 1973
Primary brain tumors: tumor immunity and immunocompetence
G M Mavligit, J U Gutterman, E M Hersh
Cancer Treatment Reviews
|
March 1, 1974
Perspectives in immunotherapy of lung cancer
E M Hersh, J U Gutterman, G M Mavligit
Pathobiology Annual
|
January 1, 1975
Cancer and host defense mechanisms
E M Hersh, J U Gutterman, G M Mavligit
Bone Marrow Transplantation
|
January 1, 1989
Clinical studies with interferons in Philadelphia positive chronic myelogenous leukemia
M Talpaz, H Kantarjian, R Kurzrock, et al.
Seminars in Oncology
|
September 1, 1974
Immunotherapy as related to lung cancer: a review
E M Hersh, G M Mavligit, J U Gutterman
Cancer
|
January 15, 1992
Bone marrow hypoplasia and aplasia complicating interferon therapy for chronic myelogenous leukemia
M Talpaz, H Kantarjian, R Kurzrock, et al.
The Medical Clinics of North America
|
May 1, 1976
Chemoimmunotherapy of human solid tumors
J U Gutterman, G M Mavligit, E M Hersh
Journal of the National Cancer Institute
|
October 1, 1976
Effect of BCG (Tice strain) on primary sensitization to 2,4-dinitrochlorobenzene and on established delayed hypersensitivity in human malignant melanoma
G M Mavligit, J U Gutterman, E M Hersh
Page
of 34